iXensor

iXensor

iXensor

iXensor is the pioneer of mobile health. We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest, our first product, is also the world’s first FDA approved smartphone camera-based blood test dated back in 2017. The founding team of iXensor first met at Stanford University in 2011. At that time, they saw the rise of the smartphone and its potential to reshape future healthcare. In 2012, iXensor was founded in Silicon Valley and then incorporated in Taipei, Taiwan. Our interdisciplinary team combines expertise in medical engineering, biochemistry, and information technology to develop innovative digital health solutions that empower tomorrow’s connected healthcare.

Company details

6F., No.9, Aly. 2, Ln. 35, Jihu Rd. , Taipei City , Neihu Dist., 11492 Taiwan
View in map

Find locations served, office locations

Business Type:
Manufacturer
Industry Type:
Medical Monitoring
Market Focus:
Globally (various continents)

This company also provides solutions for other industrial applications.
Please, visit the following links for more info:

Our product lines cover Women’s Health, Chronic, and Infectious Diseases and are powered by our core technology – PixoTech® platform protected by more than 70 international patents. PixoTech® serves as the platform-as-a-service model and will be the engine for our next phase of growth.

We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.

To facilitate data-driven healthcare with instant medical tests and seamless data synchronization.

To make quality healthcare accessible and timely for all.

2022
  • iXensor announced strategic partnership with Innova Medical Group at MEDICA
  • PixoTest® POCT COVID-19 Antigen Self-Test Kit received TFDA EUA in Taiwan.
  • iXensor Received Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement.
2021
  • PixoTest® POCT COVID-19 Antigen Test won 2022 Taiwan Excellence Gold Award.
  • PixoTest® POCT COVID-19 Antigen Test received National Innovation Award.
  • PixoTest® POCT COVID-19 Antigen Test received the CE-IVD mark in Europe, TFDA EUA in Taiwan and TGA approval in Australia.
  • PixoTech® trademark approved in the EU, USA and Taiwan
  • Eveline Smart Fertility System awarded SHOPLINE Brand Award
2020
  • Invited by Johnson & Johnson Innovation to become a resident at JLABS @ Shanghai
  • PixoTest® POCT system - HbA1c received approval from Health Sciences Authority in Singapore
  • Selected in Plug & Play's Startup Creasphere program by Roche.
  • Eveline Smart Fertility System awarded National Parenting Product Awards.
  • iXensor appointed Dr. Peter Fitzgerald as new Chairman and Dr. Carson Chen
    as new CEO to develop and execute its global growth strategy
2019
  • iXensor selected as Merck Accelerator partner.
  • PixoTest A1c Monitoring System got 510(k) clearance.
  • PixoTest Lipid Monitoring System TFDA certified.
  • PixoTest POCT System awarded German Design Award.
  • PixoTest POCT System awarded Taiwan Excellence.
  • Eveline Smart Fertility System awarded German Design Award.
2018
  • PixoTest POCT System (Lipid, A1c) got CE certificate.
  • Chosen as the representative of Taiwan to participate the Mobile World Congress (MWC) in Spain.
  • Presented HbA1c monitoring system at Advanced Technologies & Treatments for Diabetes (ATTD), Vienna.
  • iXensor chosed to be the CES representative of Taiwan.
  • Eveline Smart Fertility System won CES 'the best of babyTech' award.
2017
  • PixoTest POCT got NGSP certificate.
  • PixoTest Blood Glucose Monitoring System (BGMS) got FDA 510(k) clearance
  • Eveline Smart Fertility System awarded Taiwan Excellence Award, Taiwan.
  • Eveline Smart Fertility System awarded Good Design Award, Japan.
  • PixoTest BGMS awarded Digital Health Award.
  • PixoTest BGMS's clinical trial published on national journal, JDST
2016
  • PixoTest® BGMS pass Geman IDT clinical trial
  • PixoTest® BGMS Taiwan TFDA certified
2015
  • Pass ISO unannounced audit
  • GMP certified
  • Awarded first US patent
2014
  • Finalist of 2014 Medica eHealth Innovation Award
  • PixoTest® BGMS got CE certificate
  • ISO 13485 certificated
2012
  • iXensor established